Cardiovascular risk assessment with oxidised LDL measurement in postmenopausal women receiving intranasal estrogen replacement therapy

Kurdoglu, MERTİHAN; Yildirim, Mulazim; KURDOĞLU, ZEHRA; ERDEM, AHMET; ERDEM, MEHMET; Bilgihan, Ayse; Goktas, Bulent

doi:10.3109/09513590.2010.501879

Cardiovascular risk assessment with oxidised LDL measurement in postmenopausal women receiving intranasal estrogen replacement therapy

Copy For Citation

Kurdoglu M., Yildirim M., KURDOĞLU Z., ERDEM A., ERDEM M., Bilgihan A., ...More

GYNECOLOGICAL ENDOCRINOLOGY, vol.27, no.8, pp.551-557, 2011 (SCI-Expanded)

Publication Type: Article / Article
Volume: 27 Issue: 8
Publication Date: 2011
Doi Number: 10.3109/09513590.2010.501879
Journal Name: GYNECOLOGICAL ENDOCRINOLOGY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.551-557
Keywords: Oxidised LDL, cardiovascular risk, postmenopausal woman, hormone replacement therapy, intranasal estrogen, progesterone, CORONARY-ARTERY ATHEROSCLEROSIS, DENSITY-LIPOPROTEIN PARTICLES, RANDOMIZED CONTROLLED-TRIAL, CHOLESTEROL-FED RABBITS, HORMONE-REPLACEMENT, MEDROXYPROGESTERONE ACETATE, OXIDATIVE SUSCEPTIBILITY, AORTIC ACCUMULATION, MENOPAUSAL WOMEN, EQUINE ESTROGEN
Gazi University Affiliated: Yes

Abstract

Objective. To investigate the effect of intranasal estrogen replacement therapy administered to postmenopausal women alone or in combination with progesterone on markers of cardiovascular risk.